Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GH NYSE:HIMS NASDAQ:OPCH NASDAQ:PRVA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$54.79-0.2%$53.91$20.14▼$68.00$6.85B1.462.22 million shs2.41 million shsHIMSHims & Hers Health$54.02-2.7%$50.38$15.73▼$72.98$12.54B2.1424.77 million shs27.98 million shsOPCHOption Care Health$27.89-2.1%$29.03$21.39▼$35.53$4.62B0.821.86 million shs1.35 million shsPRVAPrivia Health Group$22.34-2.0%$21.13$16.47▼$26.09$2.80B0.82682,091 shs532,733 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health-0.20%-8.94%-6.95%+10.62%+104.52%HIMSHims & Hers Health-2.63%+8.55%+17.21%-8.70%+226.01%OPCHOption Care Health-2.07%-5.75%-1.52%-12.41%-12.82%PRVAPrivia Health Group-1.97%-5.30%+5.03%-0.22%+17.89%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$54.79-0.2%$53.91$20.14▼$68.00$6.85B1.462.22 million shs2.41 million shsHIMSHims & Hers Health$54.02-2.7%$50.38$15.73▼$72.98$12.54B2.1424.77 million shs27.98 million shsOPCHOption Care Health$27.89-2.1%$29.03$21.39▼$35.53$4.62B0.821.86 million shs1.35 million shsPRVAPrivia Health Group$22.34-2.0%$21.13$16.47▼$26.09$2.80B0.82682,091 shs532,733 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health-0.20%-8.94%-6.95%+10.62%+104.52%HIMSHims & Hers Health-2.63%+8.55%+17.21%-8.70%+226.01%OPCHOption Care Health-2.07%-5.75%-1.52%-12.41%-12.82%PRVAPrivia Health Group-1.97%-5.30%+5.03%-0.22%+17.89%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.06Buy$58.246.29% UpsideHIMSHims & Hers Health 1.92Reduce$38.92-27.96% DownsideOPCHOption Care Health 2.89Moderate Buy$35.7528.18% UpsidePRVAPrivia Health Group 2.93Moderate Buy$28.5827.95% UpsideCurrent Analyst Ratings BreakdownLatest PRVA, HIMS, GH, and OPCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/12/2025HIMSHims & Hers HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$68.009/4/2025GHGuardant HealthBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $70.009/4/2025PRVAPrivia Health GroupStephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$32.008/29/2025PRVAPrivia Health GroupJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$29.00 ➝ $30.008/29/2025PRVAPrivia Health GroupCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform8/19/2025HIMSHims & Hers HealthZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/19/2025PRVAPrivia Health GroupZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/18/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$48.00 ➝ $37.008/11/2025PRVAPrivia Health GroupPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$36.00 ➝ $35.008/5/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold7/31/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$36.00 ➝ $38.00(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$828.85M8.24N/AN/A($1.13) per share-48.49HIMSHims & Hers Health$1.48B8.27$0.34 per share157.60$2.16 per share25.01OPCHOption Care Health$5.37B0.84$1.61 per share17.31$8.25 per share3.38PRVAPrivia Health Group$1.74B1.58$0.18 per share126.30$5.70 per share3.92Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%11/5/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.8067.53103.883.759.63%26.26%13.06%11/3/2025 (Estimated)OPCHOption Care Health$211.82M$1.2522.3122.131.733.93%17.53%7.17%10/29/2025 (Estimated)PRVAPrivia Health Group$14.39M$0.11203.1182.743.300.78%2.13%1.25%11/6/2025 (Estimated)Latest PRVA, HIMS, GH, and OPCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025PRVAPrivia Health Group$0.05$0.02-$0.03$0.02$466.97 million$521.15 million8/4/2025Q2 2025HIMSHims & Hers Health$0.18$0.17-$0.01$0.17$550.06 million$544.83 million7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 million7/30/2025Q2 2025OPCHOption Care Health$0.40$0.41+$0.01$0.31$1.35 billion$1.42 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A3.713.35HIMSHims & Hers Health1.724.984.46OPCHOption Care Health0.811.521.00PRVAPrivia Health GroupN/A1.651.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%PRVAPrivia Health Group94.48%Insider OwnershipCompanyInsider OwnershipGHGuardant Health6.10%HIMSHims & Hers Health17.71%OPCHOption Care Health0.64%PRVAPrivia Health Group10.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health2,021124.71 million117.10 millionNot OptionableHIMSHims & Hers Health1,637226.02 million185.99 millionOptionableOPCHOption Care Health8,088162.30 million161.26 millionOptionablePRVAPrivia Health Group1,140122.73 million109.60 millionOptionablePRVA, HIMS, GH, and OPCH HeadlinesRecent News About These CompaniesUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Grows Stake in Privia Health Group, Inc. $PRVA3 hours ago | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Receives Consensus Rating of "Moderate Buy" from Brokerages3 hours ago | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of "Moderate Buy" by BrokeragesSeptember 15 at 2:37 AM | americanbankingnews.comDynamic Technology Lab Private Ltd Has $1.15 Million Position in Privia Health Group, Inc. $PRVASeptember 10, 2025 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) May Have Issues Allocating Its CapitalSeptember 9, 2025 | finance.yahoo.comPrivia Health Group (NASDAQ:PRVA) Receives "Overweight" Rating from StephensSeptember 6, 2025 | marketbeat.comCinctive Capital Management LP Purchases 114,478 Shares of Privia Health Group, Inc. $PRVASeptember 6, 2025 | marketbeat.comAlTi Global Inc. Sells 50,000 Shares of Privia Health Group, Inc. $PRVASeptember 6, 2025 | marketbeat.comPDT Partners LLC Takes $1.94 Million Position in Privia Health Group, Inc. $PRVASeptember 5, 2025 | marketbeat.comPrivia Health Group, Inc. $PRVA Shares Acquired by Trexquant Investment LPSeptember 5, 2025 | marketbeat.comBreaking Down Privia Health Gr: 4 Analysts Share Their ViewsSeptember 4, 2025 | benzinga.comWilliam Blair Has Positive Outlook for PRVA Q3 EarningsSeptember 2, 2025 | marketbeat.comNorthern Trust Corp Raises Stake in Privia Health Group, Inc. $PRVASeptember 1, 2025 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Shares Gap Up - Should You Buy?August 31, 2025 | marketbeat.comHsbc Holdings PLC Has $1.49 Million Stock Position in Privia Health Group, Inc. $PRVAAugust 31, 2025 | marketbeat.com41,062 Shares in Privia Health Group, Inc. $PRVA Acquired by Epoch Investment Partners Inc.August 30, 2025 | marketbeat.comWhy Is Privia Health (PRVA) Stock Soaring TodayAugust 29, 2025 | uk.finance.yahoo.comPrivia Health Group Reports Highest Savings Rate among ACOs with 40,000+ Lives and Increases 2025 EBITDA GuidanceAugust 28, 2025 | quiverquant.comQPrivia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year IncreaseAugust 28, 2025 | globenewswire.comPrivia Health Group, Inc. $PRVA Shares Sold by T. Rowe Price Investment Management Inc.August 27, 2025 | marketbeat.comPrivia Health Group, Inc. $PRVA Shares Purchased by Quantbot Technologies LPAugust 27, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025Amazon Stock Sets Up for Breakout After Bullish CrossoverBy Sam Quirke | August 21, 2025Take Profits Now: 3 Overbought Stocks Primed for a PullbackBy Dan Schmidt | August 25, 2025NVIDIA Stock Could Pull Back in September, But Don’t Bet on ItBy Thomas Hughes | August 28, 2025PRVA, HIMS, GH, and OPCH Company DescriptionsGuardant Health NASDAQ:GH$54.79 -0.11 (-0.20%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$54.72 -0.07 (-0.13%) As of 09/15/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$54.02 -1.48 (-2.67%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$54.35 +0.33 (+0.61%) As of 05:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$27.89 -0.59 (-2.07%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$27.88 0.00 (-0.02%) As of 09/15/2025 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Privia Health Group NASDAQ:PRVA$22.34 -0.45 (-1.97%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$22.23 -0.11 (-0.49%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Reddit Hits Record Highs: Why Wall Street Is Taking Notice Royal Caribbean's 33% Dividend Hike Signals Deeper Growth FuelCell Energy's Stock: Is a Fundamental Breakout Underway? After a Strong Wall Street Debut, Klarna's Real Work Begins MarketBeat Week in Review – 09/08 - 09/12 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
